Myeloid-derived suppressor cells (MDSCs) are newly identified immature myeloid cells that
are characterized by the ability to suppress immune responses and expand during cancer …

Background Myeloid-derived suppressor cells (MDSCs) is a heterogeneous population of
immature myeloid cells, inhibiting both the innate and adaptive immunity. Recent studies …

Introduction Immune escape frequently occurs and restricts the durability of the antitumor
immune response to radiotherapy. Programmed death 1 (PD-1) and programmed death …

Myeloid-derived suppressor cells (MDSC) are induced under diverse pathologic conditions,
including neoplasia, and suppress innate and adaptive immunity. While the mechanisms by …

Over recent decades, various studies have argued that the metastatic tissue
microenvironment is fully controlled by the intrinsic properties of the cancer cells (growth …

Myeloid-derived suppressor cells (MDSC) present in the human peripheral blood, represent
a heterogeneous population of cells with monocytic and granulocytic features. To provide …

Enhanced bone destruction is a hallmark of various carcinomas such as breast cancer,
where osteolytic bone metastasis is associated with increased morbidity and mortality …

Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature
myeloid cells that accumulate during pathological conditions such as cancer and are …

Myeloid-derived suppressor cells (MDSC) play a significant role in tumor-induced immune
suppression. Targeting their function could improve antitumor therapies. Previously, we …

Immune escape mechanisms promote tumor progression and are hurdles of cancer
immunotherapy. Removing immunosuppressive cells before treatment can enhance …